In this episode, Alli speaks on functional mushrooms for health: what they are, why they’re important, and what benefits they provide. She also delves into how functional mushrooms, when combined with psychoactive mushrooms such as psilocybin, impact the body.
GoDaddy Founder Bob Parsons talks to Psychedelic Spotlight about treating PTSD with MDMA-assisted psychedelic therapy
In today’s episode, James from PSYCBiz interviews Robert Barrow, CEO of Mindmed (NASDAQ: MNMD) (NEO: MMED). PSYCBiz had recently asked the investors from the Reddit community r/MindMedInvestorsClub to participate in an AMA with Rob Barrow. The top 5 voted questions were discussed on this panel. These were: 1. With the biotech industry taking a hit, […]
In today’s episode of PsycBiz, James —the Psychedelic Investor— sits down with Mark Haden, VP of Business Development for Clearmind Medicine (CSE: CMND, OTC Pink: CMNDF, FSE: CWY0). Clearmind is a next-gen psychedelics company working on treating addiction. Their main candidate is a next-gen psychedelic called MEAI. Currently, MEAI is being researched as a treatment […]
In this episode, Christi provides insight into how ketamine impacts people’s physical and mental health. She goes into the comparison of ketamine’s effects compared to other psychedelics and how Flow Integrative’s patient care is unique.
GoDaddy Founder Bob Parsons talks to Psychedelic Spotlight about his time in Vietnam, PTSD, and his healing journey with psychedelics
Can wearable technology help alleviate stress? Apollo Neuro’s new wearable shows amazing promise
In this episode, Dr. Khamsehzadeh delves into our historical and ancestral relationship to psilocybin and theorizes how mushrooms have impacted the development of the brain.
This week in psychedelic business news: Cybin acquires a Phase 1 DMT trial from Entheon; Numinus completed the acquisition of Novamind, MindMed’s stock is removed from an index; and more! Cybin Acquires DMT Clinical Study from Entheon Biomedical On June 7th, 2022, Cybin Inc. (NYSE: CYBN, NEO: CYBN) announced that they have entered into an […]
In today’s episode, Myriam describes the impact of ketamine on the mind and the body, and specifically how ketamine therapy compares to other psychedelic-assisted therapies.
